Natco Pharma Receives In-Principal Approval for Rights Issue

Natco Pharma Ltd has received in-principle approval from both the National Stock Exchange of India Limited and BSE Limited for its upcoming Rights Issue of fully paid-up equity shares. The approval was granted on September 21, 2026. Further details and the approval letters are available on the company's investor relations website.